Compare CC & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CC | MIR |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Industrial Machinery/Components |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 5.7B |
| IPO Year | N/A | N/A |
| Metric | CC | MIR |
|---|---|---|
| Price | $12.94 | $24.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $17.00 | ★ $28.29 |
| AVG Volume (30 Days) | 2.4M | ★ 3.3M |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | ★ 2.70% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | ★ $5,837,000,000.00 | $902,300,000.00 |
| Revenue This Year | $3.34 | $8.15 |
| Revenue Next Year | $4.20 | $19.02 |
| P/E Ratio | ★ N/A | $242.75 |
| Revenue Growth | 0.03 | ★ 7.82 |
| 52 Week Low | $9.13 | $12.00 |
| 52 Week High | $20.12 | $30.28 |
| Indicator | CC | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 46.51 |
| Support Level | $12.09 | $24.52 |
| Resistance Level | $13.42 | $26.36 |
| Average True Range (ATR) | 0.62 | 1.03 |
| MACD | 0.17 | 0.02 |
| Stochastic Oscillator | 81.64 | 31.93 |
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.